Strona Badania kliniczne Nct

Clinical Trial Results:
A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and Adolescents

Summary
EudraCT number
2004-003941-42
Trial protocol
SE  
Global completion date
21 Aug 2006

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
16 Sep 2018
First version publication date
16 Sep 2018
Other versions
Summary report(s)
LY15 Synopsis
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Subskrybuj